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CHAPTER I 
1. INTRODUCTION 
1.1.Anatomy of liver 
The liver is one of largest gland in the body and after the dermis1. The liver 
weights about three and a half pounds (1.6 kg). It constitutes about 2.5% of 
adult’s body weight2. It is located in the upper part of the abdomen that aids in 
digestion and removes waste products and worn-out cells from the blood. 
Liver is connected to two large blood vessels which include hepatic artery and 
portal vein2. Thirty percentage blood was pumped by the heart for one minute 
for body’s chemical factorial organ called liver. Liver cleanses blood and 
processes nutritional molecule that are distributed to the tissues.  Liver accept 
nutritional red blood by portal circulation from lungs which has filled with 
essential oxygen supplied to heart.  It is situated in the upper part of the 
abdominal cavity, inferior to the diaphragm occupying the greater part of the 
right hypochondriac region, part of the epigastric region and extending into the 
left hypochondriac region. Its upper and anterior surfaces are smooth and 
curved to fit the under surface of the diaphragm and its posterior surface is 
irregular in outline3. The different types of cells propagate from the liver lobes 
are parenchymal and non-parenchymal type of cells. Majority (about 80%) of 
the liver mass is filled by parenchymal type of cells commonly known as 
hepatocytes. the other type non-parenchymal type cells having forty 
percentage of the total counts of the liver cells but it have 6.5% of its total 
volume2. It also release about two and one-half ml of the bile in its own ducts 
which is delivered by a gallbladder via congested tube called the cystic duct 
for storage of these bile. Liver is regulated for this gland that control as to 
whether these incoming substances was useful for body or whether they are 
needless. Liver is an extremely important organ and exhibits multiple 
functions. Liver detoxifies for blood cells by proper fixation of bile solution via 
chemical modification to form less toxic substances, example alteration of 
ammonia to urea. Many chemical substances are inactivated by liver through 
modification of chemical structure. Liver convert glucose to glycogen as a 
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storage form of energy and it produces glucose from disaccharides and 
polysaccharides such as sugars, starches and protein molecules 
Figure. No: 1: Location of liver in Human Digestive System4 
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 The liver is situated below the diaphragm which occupy  right side of hypochondriac 
and region in the abdominopelvic cavity. The liver is completely covered by a 
dense irregular connective tissue layer that lies deep to the peritoneum. It   is 
divided into two principal lobes-a large right lobe and a smaller, wedge-
shaped, left lobe separated by the falciform ligament.  Right lobe is described 
by many anatomists to have an inferior quadrate lobes and a posterior 
caudate type lobes. The falciform ligament extends from undersurface of the 
diaphragm from the upper surface of the liver part, between two significant 
lobes of the liver, helped to suspend the liver. Liver is composed of several 
components:          
Hepatocytes are the functional cells of the liver which are arranged in pairs of 
columns radiating from a central vein. A wide range of metabolic, secretory 
and endocrine functions are performed by hepatocytes. These are specialized 
epithelial cells with 5-12 sides that make-up about 80% of the volume of the 
liver. Hepatocytes form complex three dimensional arrangements called 
hepatic laminae and they are the sheet of hepatocytes one cell thick lined to 
either side by the endothelial-lining spaces called hepatic sinusoids. Grooves 
inside the cell surface between neighboring hepatic cells which provide gaps 
for the canaliculi of hepatocytes that secrete bile. Bile is a yellow, brown, or 
olive-green colur type liquid which secreted from hepatic cells, which provide 
an excretory product and a digestive enzyme secretor. 
Bile canaliculi are narrow intercellular canals that collect bile secreted by 
hepatocytes. From bile canaliculi, bile passes into small bile ducts. These 
small ducts combined by form the higher right and left hepatic void that 
commonly connect and exit the liver via common hepatic duct. This common 
hepatic duct joins the cystic duct from the gallbladder to form the common bile 
duct. Bile enters the cystic duct and temporarily stored in the gallbladder. After 
a meal, various stimuli cause contraction of the gallbladder, which releases 
stored bile into the common bile duct. 
Hepatic sinusoids are freely permeable capillaries about sheets of liver cells 
that get oxygenated blood via different branches of hepatic artery and higher 
amount of nutrient rich de-oxygenated blood from the branches of the hepatic 
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portal vein system. The hepatic portal vein helped to take the venous blood 
via gastrointestinal organs and spleen into the liver. Hepatic sinusoids convert 
and it delivered blood from the central vein blood cells.  Blood flows from 
central veins into hepatic veins that drain into the inferior venacava. In 
opposite of the blood which flows toward important vein, bile flows towards 
the opposite side. The sinusoids are partly lined with stellate 
reticuloendothelial (Kupffer’s) cells that destroy worn-out WBC and RBC, 
bacteria and other foreign substance in blood. Bile duct have part in the 
hepatic artery, and branch of hepatic vein are referred to as portal triad. 
Figure.No:2:Liver showing right and left lobes separated by Falciform   
Ligament5 
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The hepatocytes, bile duct contents and hepatic sinusoids are organized into 
an anatomical and functional units by three different types: 
 Hepatic lobule: For many years, anatomy fellow are suggest that the 
hepatic lobule are liver’s functional units. They describes the each hepatic 
lobule are shaped as that of a hexagonal. At its center is central vein 
emerging out by they form a rows of hepatocytes and hepatic sinusoidal cells. 
This model is suggested by detailed autopsy of the liver of the adult pigs. 
From the study of human liver have not predicted the hepatic lobules anatomy 
having a thick layers of connective tissues type. 
Portal lobule: This model emphasized the endocrine function of the liver, 
i.e., bile release. According to the bile ducts in a portal triad is consider as the 
middle of the portal lobules. These portal lobule’s are triangular shaped and is 
having a 3 imaginary straight lines which connect three central veins which 
are near by the portal triad. These model which are not gained wide spread 
acceptance.  
Hepatic acinus: In past years, the accepted structural and functional unit of 
the liver known as the hepatic acinus.  These are approximately oval shape 
mass which includes portions of two neighboring hepatic lobules.  Small axis 
of hepatic acinus is described by the branches of the portal triad- branches 
contain a hepatic artery, hepatic vein and bile ducts.  Long axis of the acinus 
inter connected closest to short axis. Hepatocytes in the hepatic acinus are 
arranged in three zones from its short axis, with no sharp among them. Cells 
inside the zone 1 are closer to branches of portal triad and these cells are first 
to accept oxygen, essential food material and toxins from the receiving blood 
cells. These cells are gain-up glucose and save it by converting glycogen after 
food ingestion, so during fasting period get the energy via glycogen to 
glucose. These are first shows the characteristic morphological changes. 
Zone 1 cells are last ones to die when circulation is impaired and the first 
ones to regenerate. Cells in zone three are much farther from branches of 
portal triad and are the last to show the effects of bile blockage or presence to 
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toxins, the first ones effect is the abnormal circulation, retarded o rate of 
regeneration and evidence of fat accumulation. The cells in zone 2 show 
structural and functional characteristics intermediate between cells in zone 1 
to 3.  
 1.1.1.Blood supply of liver 
 The liver receives blood from two sources, hepatic artery and hepatic portal 
vein. From hepatic artery it obtains oxygenated blood and from hepatic portal 
vein it receives deoxygenated blood that contains newly absorbs essential 
nutrients, therapeutic molecules, and possibly nonpathogenic microorganism 
and may receive toxins from the gastrointestinal tract. Branches of both 
hepatic artery and portal vein carry blood into liver sinusoids where 
hepatocytes extracts oxygen most of the nutrients and certain poisons. 
Nutrients needed by other cells and products manufactured by the 
hepatocytes are secreted back into the blood  After blood passed inside 
central vein and eventually passes via hepatic vein. Branches of hepatic 
portal vein, artery and bile duct typically accompany each other in their 
distribution through liver. Collectively these three structures are called portal 
triad1.  
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Figure. No: 3: - Hepatic blood flow path: source of blood, passing through 
the liver and return back to the heart3 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
   
1.1.2.Functions of liver 
The liver has well over 500 functions and is known as the laboratory of human 
body. The liver is tied to almost all the bodily processes as it is responsible for 
filtration of all incoming foods and fluids6.      
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1.1.2.1. Carbohydrate metabolism 
Liver is important in maintaining normal blood glucose level.  Liver can 
break down glycogen to glucose (glycogenolysis) and release glucose into the 
bloodstream, when blood glucose level decreases.  Liver helped the 
conversion of certain amino acid by glucose through lactic acid 
(gluconeogenesis) and convert other sugar molecules such as fructose and 
galactose reduced to glucose. Liver converts glucose to glycogen 
(glycogenesis) and also undergoes the covertion of triglycerides (lipogenisis). 
1.1.2.2. Lipid metabolism 
Liver stores some triglycerides from fatty acids through acetyl 
coenzyme A known as beta oxidation. It possibly converts excess acetyl 
coenzyme A to ketone bodies (ketogenesis). It synthetize lipoproteins, that 
transportation of fatty acids, triglycerides (TG) and cholesterol from the body 
cells. Cholesterol is synthesized by hepatocytes and  cholesterol involves the 
formation of bile salts. 
1.1.2.3. Protein metabolism 
  Most of the plasma proteins, such as α and β globulins, glycol proteins 
(albumin and fibrinogen) are synthesized from liver cells. Also, liver enzymes 
can perform transamination. Liver deaminates amino acids so that they are 
used in the ATP synthesis or conversion from carbohydrates or fats. It 
converts resulting toxic ammonia into much less toxic urea for excretion in 
urine. 
1.1.2.4. Removal of drugs and hormones 
 Liver can detoxify substances such as alcohol or excrete drugs like penicillin, 
erythromycin, and so on into bile. It is also trigger or chemically alter thyroid 
hormones and steroid hormones (estrogens and aldosterone). 
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1.1.2.5. Excretion of bilirubin 
Bilirubin released from heme of red blood cells is absorbed in the liver through 
the blood and release to bile. Most of bilirubin in bile is metabolized in the 
intestine by bacteria and eliminated in feces.  
1.1.2.6. Synthesis of bile salts 
These are helped in small intestine functioning as an emulsification process 
and absorption of lipid molecules, cholesterol, phospholipids, and lipoproteins. 
1.1.2.7. Storage 
In addition to glycogen, liver stores water soluble and fat-soluble vitamins (A, 
B12, D, E, and K) and essential minerals (iron and copper). Hepatocytes 
contain a protein called apoferritin that combines with iron to form ferritin, the 
form in which iron is stored in liver. The iron is secreated from the liver is 
essential requirement of the body. 
1.1.2.8.  Phagocytosis 
The stellate reticuloendothelial (Kupffer’s) cells of the liver phagocytize worn-
out red and white blood cells and some type of the bacteria. 
1.1.2.9. Activation of vitamin D 
The cutaneous layer of skin, liver and kidneys essential for activation 
vitaminD1. 
1.1.2.10. Secretion and excretion of Bile 
Bile is an incomplete synthetic substance and partially act as  digestive 
secretion. Each day hepatic cells secrete 800-1000ml of bile. It has a PH of 
7.6-8.6. Bile mainly consist water, bile salts, cholesterol and phospholipid 
known as lecithin, bile pigments and several ions. Principle bile pigment is 
bilirubin6. 
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1.1.2.11. Synthesis of vitamin A from carotene 
Carotene is the pro-vitamin found in some plants for example carrots and 
green leaves of vegetables. 
1.1.2.12. Production of heat 
Liver able to create amount of energy which has a high metabolic rate and 
produces considerable amount of heat. It is an important heat producing 
organ of body3. 
1.1.3.Pathology of liver7 
All forms of injury to the liver such as microbiologic, toxic, circulatory or 
traumatic result in necrosis in liver. The extent of involvement of hepatic 
lobules necrosis varies. Accordingly, liver cell necrosis are divided into 3 
types: diffuse (submissive to massive), zonal and focal.           
1.1.3.1.Diffuse (Submassive to massive). 
When there is extensive and diffuse necrosis of the liver involving all the cells 
in groups of lobules, it is termed diffuse, or submissive to massive necrosis. It 
is most commonly caused by viral hepatitis or drug toxicity. 
    1.1.3. 2.  Zonal necrosis. 
Zonal necrosis is necrosis of hepatocytes in three different zones of the 
hepatic lobule as shown in the figure below. 
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                     Figure. No: 4:  Histology of Hepatic lobule7 
             
Accordingly, it is of three types, each type affecting respective zone is caused 
by different etiologic factors: 
i. Centrilobular necrosis is the commonest type involving hepatocytes 
in zone 3 (i.e. located around the central vein). Centrilobular 
necrosis is characteristic feature of ischemic injury such as in shock 
and CHF since zone 3 is farthest from the blood supply. Besides, it 
also occurs in poisoning with chloroform, carbon tetrachloride and 
certain drugs. 
ii. Mid-zonal necrosis is uncommon and involves zone 2 of the hepatic 
lobule. This pattern of necrosis is seen in yellow fever and viral 
hepatitis. In viral hepatitis, some of the necrosed hepatocytes of the 
mid-zone are transformed into acidophilic, rounded Councilman 
Bodies. 
iii. Periportal (peripheral) necrosis is seen in zone 1 involving the 
parenchyma closest to the arterial and portal blood supply. Since 
zone 1 is most well perfused, it is most vulnerable to the effects of 
circulating hepatotoxins e.g. in phosphorus poisoning 
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1.1.3.3. Focal Necrosis 
This form of necrosis involves small groups of hepatocytes irregularly 
distributed in the hepatic lobule. Focal necrosis is most often caused by 
microbiological infections. These include viral hepatitis, military tuberculosis, 
typhoid fever and various other forms of bacteria, viral and fungal infections. 
Focal necrosis may also occur in drug-induced hepatitis. 
 1.1.4.Enzymes involved with liver 
1.1.4.1.Alanine transaminase 
  Alanine transaminase or ALT is a transaminase, serum glutamic–
pyruvic transaminase (SGPT or also known as alanine aminotransferase 
(ALAT)) commonly observed in many tissues and body fluids principally in 
liver. ALT is released into serum as a result of tissue injury8 
i.Function 
ALT catalyzes the reversible transfer of an amino groups in the L-alanine 
enzyme to α-ketoglutarate proteins forms such as pyruvate and L-glutamate. 
L-Glutamate + Pyruvate        ↔    α-Ketoglutarate   +   L-
Alanine 
ii.Clinical Significance 
It is commonly estimated clinically as a parameter of diagnostic 
evaluation of hepatocellular injury in order to determine liver health. ALT has 
actually measured by international units/liter (IU/L) 9&10 when used in 
diagnosis. 10-40 IU/L are the standard reported range of experimental 
studies11. 
iii.Elevated levels 
Significantly abnormal range of Alanine transaminase (ALT) often 
suggest the abnormality of conditions including viral hepatitis, diabetes 
mellitus induced cell necrosis, heart failure, liver injury, infectious 
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mononucleosis, bile duct problems and myopathy. Because of these reason, 
ALT is one of the important parameter used for screening of liver diseases.  
Dietary choline deficiency shows marked elevation in ALT levels.  These 
enzyme variation levels of ALT do not have significance of  that medical 
problem is present. Fluctuation of ALT level is normal during course of day 
and ALT levels can increase in response to strenuous physical excercise11. 
When elevated ALT levels are found in blood concentration subsequently 
narrowed down by measuring other enzyme concentration (example liver- cell 
damage usually distinguished from biliary duct problems by measuring 
increased ALP).  Myopathy-related ALT levels can be found out by measuring 
the creatine kinase enzymes. Several drugs elevate ALT levels, for example, 
Zileuton. For years, American Red Cross society used for ALT testing as part 
of the key enzyme of tests to ensure the safety of its blood pumping by 
deferring donors with elevated ALT levels. Main reason was to specify donors 
have an infection with Hepatitis C because there is a no specific test available 
for these12.  
1.1.4.2.Aspartate transaminase 
Aspartate Transaminase (AST) also called Aspartate Aminotransferase 
(ASAT/AAT/AspAT) or Serum Glutamic Oxaloacetic Transaminase (SGOT), is 
a transaminase enzyme containing pyridoxal phosphate. AST catalyses 
reversible transfer of α-amino group between aspartate and glutamate .it is a 
key enzyme required for amino acid metabolism in human. It commonly 
present in liver, heart, skeletal muscle, kidneys, brain and red blood cells and 
AST is commonly measured clinically as a marker for liver health.  It is also 
associated with liver parenchymal cell metabolism. The ratio of AST/ALT is 
may be useful for differentiation between etiology of liver damage 13, 14.   
Reference range is 6-40IU/L15. 
i.Function 
AST catalyzes the interconversion of aspartate and α-ketoglutarate to 
oxaloacetate and glutamate.  
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Aspartate (Asp) + α- Ketoglutarate ↔ Oxaloacetate + 
Glutamate (Glu) 
As prototypical transaminase AST relies on PLP as a cofactor to transfer 
amino group from aspartate or glutamate to corresponding ketoacid16. 
iii.Isoenzymes 
Two isoenzymes are present in wide variety of eukaryotes. In humans, 
i. GOT1 / c AST, the cytosolic iso enzyme synthesized mainly from red 
blood cells and heart. 
ii. GOT2 / m AST, the mitochondrial isoenzyme present predominantly in 
liver. 
These isoenzymes are considered to be evolved from a common 
gene duplication and subsequent synthesi17. 
iv.Clinical significance: 
It is raised in liver inflammation. It is also elevated in diseases such as 
myocardial infaraction, acute pancreatitis, nephrotoxicity, hemotoxicity, 
musculoskeletal diseases and trauma. AST was used initially biochemical 
marker for diagnosis of acute myocardial infarction but now redundant and 
has been superseded by the cardiac troponins18.  AST is commonly measured 
clinically as a part of diagnostic liver function test inorder to determine liver 
health. 
Reference range- 
Male 8-40IU/L 
Female 6-34IU/L 
1.1.4.3.Alkaline phosphatase 
Alkaline phosphatase (ALP) have functioning towords removing phosphate 
group containing molecules such as nucleotides, proteins, and alkaloids. 
Process of removing phosphate group is called de-phosphorylation. By the 
maintaince of effective and also alkaline environment. It is sometimes used 
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similarly as basic phosphatase19. ALP is mainly present in cells lining of the 
biliary ducts. 
i.Elevated levels 
ALP levels in plasma increase due to large bile duct constriction, 
intrahepatic cholestasis. ALP is found also in bone and placental tissue and 
hence higher in growing children and elderly patients haveing Paget’s 
disease. In third trimester of pregnancy ALP is two to three times higher. 
ii.Reference range:  30-120 IU/L20.Liver (ALP): Cholestasis, cholecystitis, 
cholangitis, cirrhosis, hepatitis, fatty liver, sarcoidosis, liver tumor, liver 
metastases, drug intoxication21. Placental ALP is elevated in seminomas22 
and active form of rickets as well as in following diseases23. 
 Biliary construction. 
 Bone conditions. 
 Osteoblastic bone cancer. 
 Osteomalacia. 
 Liver disorder/ hepatitis. 
 Leukemia. 
 Lymphoma. 
 Paget’s disease. 
 Sarcoidosis. 
 Hyperparathyroidism. 
iii.Lowered levels 
 Following diseases may lead to decreased levels of alkaline phosphatase- 
 Hypophosphatasia (autosomal recessive disease). 
 Postmenopausal women undertaking estrogen therapy due to 
osteoporosis. 
 Hypothyroidism or severe anemia. 
 Children affected with achondroplasia and cretinism. 
 Children who are victims of severe episode of enteritis. 
                                                                                       
 
 Page 16 
 
 Pernicious and aplastic anemia. 
  myelogenous leukemia. 
 Wilson’s disease. 
Apart from these, the following chemicals are clinically studied to reduce 
alkaline phosphatase: Oral contraceptives24. 
1.1.4.4.Total protein 
Total protein includes total amount of two classes of proteins present in fluid 
portion of blood. These include albumin and globulin. Total protein tests 
measures amount of albumin and globulin which are major groups of protein 
in blood. A low total protein level due to liver disorder, kidney disorder or 
disorder  which protein is not digested or absorbed properly25. 
i.Normal Range:  6.0 - 8.3gm/dl  
ii.Higher -than –normal levels may be due to: 
 Chronic inflammation or infection (HIV, Hepatitis B or C). 
 Bone marrow disorders (Multiple myeloma, Waldenstroms disease). 
iii.Lower-than-normal levels may be due to: 
 Bleeding (Hemorrhage). 
 Burns (extensive). 
 Liver disease. 
 Glomerulonephritis and nephritic syndrome. 
 Malabsorption. 
  Malnutrition26. 
1.1.4.5.Total bilirubin 
       Total bilirubin (TBIL) test checks levels of bilirubin in blood. Bilirubin 
(orange-yellow pigment) is the waste product of normal break down of red 
blood cells. Bilirubin passes through liver and eventually passes out of body 
as feces and small amount in urine. Before reaching liver bilirubin is called 
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unconjugated. Inside liver it combines with certain sugars to create water 
soluble form called conjugated bilirubin27. 
i.Normal Range: 0.3 -1.9mg/dl 
ii.Clinical significance 
Total bilirubin is usually measured to screen for or to monitor liver or 
gallbladder diseases. Presence of high amount of bilirubin in body leads to 
jaundice. 
iii.Higher Levels: 
 Drug toxicity. 
 Liver diseases such as hepatitis. 
 Biliary stricture. 
 Cancer of gallbladder or pancreas. 
 Gallstones28. 
 Erythroblastosis fetalis. 
 Physiological jaundice.  
 Sickle cell anemia29. 
 HIV Infection. 
 Bacterial infection inside blood. 
 
1.1.5.Hepatotoxicity 
Liver diseases are the major medical problems faced by the people all 
over the world30. About 20,000 deaths occur every year due to liver 
disorders31. In Africa and in Asia, the main causes of liver diseases are 
viruses and parasitic infections, whereas in Europe and in North America, a 
major cause is alcohol abuse30. Liver diseases are mainly caused by toxic 
chemicals, excessive intake of alcohol, infections and autoimmune 
disorders32. Hepatotoxicity due to drug appears to be a common contributing 
factor.  Liver is expected not only to carryout physiological functions but also 
to protect against the hazardous of harmful drugs and chemicals33. Drug 
induced chemical injury is responsible for 5% of all hospital admissions and 
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50% of all acute liver failures. More than 75% of cases of immunological 
reaction of drugs leading to liver transplantation or death34. 
 Hepatotoxicity mainly implies chemical-driven liver damage. Certain 
drugs when taken in overdose and sometimes even when administered within 
therapeutic ranges may injure many organs. Some chemical agents including 
those that are used in laboratories (Ccl4, paracetamol) and industries (Lead, 
arsenic) and natural chemicals (microcystine, aflatoxins) and herbal remedies 
(cascara sagrada, ephedra) can also cause hepatotoxicity. Chemicals which 
cause liver injury are collectively known as hepatotoxins34. 
 NSAIDS35 (Acetaminophen36, Aspirin, Ibuprofen) 
 Glucocorticoids.  
 Anti-Tubercular drug (Isoniazid) 37. 
 Industrial toxins (arsenic, carbon tetrachloride, vinyl chloride). 
 Herbal remedies (Ackee fruit, camphor, cycasin, kava leaves, valerian, 
comfrey) 38. 
1.1.5.1.Pathophysiological mechanisms 
 Pathophysiological mechanisms of hepatotoxicity are still being 
identified and which include both hepatocellular and extracellular effects. 
Following are some mechanisms: 
Disruption of hepatocyte: Drugs can bind to intracellular proteins by 
covalent binding which result in a lower in ATP levels subsequent disruption. 
Splitting of actin these fibrils at the surface of the hepatocyte causes rupture 
of the membrane of liver. 
Disruption of transport protein: Bile flow may be interrupted by drugs that 
affect transport proteins at canalicular membrane. Loss of villous due to the 
interruption of transport pumps leading to multidrug resistance- associated 
protein 3 prevent excretion of bilirubin resulting in cholestasis. 
Cytolytic T-cell activation:  Covalent binding of drug to P-450 enzyme acts 
as an immunogenic activation of T-cells and cytokines leading to immune 
reaction. 
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 Apoptosis of hepatocytes:  Stimulation of these pathway may leading 
for programmed necrosis of hepatocytes. 
 Mitochondrial disruption:  Some drugs inhibit mitochondrial function 
by dual effect on both beta- oxidation energy productions by inhibiting 
the release of the e dinucleotide, subsequently reduce the ATP 
production. 
 Bile duct injury:  free radicle produced metabolites excreted in the bile 
may leading to necrosis of bile duct epithelium. 
1.1.5.2.Drug toxicity mechanisms 
 Classic division of drug reactions is of at least 2 major groups which include: 
(1) Drugs which directly affect liver.  
(2) Drugs which mediate an immune response. 
 
 Intrinsic / predictable drug reactions: molecules that fall into this 
drug category lead to reproducible injuries in mammals and injury is 
related to dose.  Injury can be due to drug itself or to metabolite. 
Acetaminophen is a suitable example of well-known predictable 
hepatotoxin at higher therapeutic doses. Another example is carbon 
tetrachloride. 
 Idiosyncratic / unpredictable drug reactions: These drug reactions 
can be subdivided into those that are classified as hypersensitivity or 
immunoallergic and those that are metabolic-idiosyncratic. It occurs 
without obvious dose-dependency and in an unpredictable fashion.39 
1.1.5.3.Symptoms  
 List of signs and symptoms depicted in various causes for Hepatotoxicity 
include 15 symptoms as listed below: 
 Nausea 
 Vomiting 
 Abdominal pain 
 Loss of appetite 
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 Diarrhea 
 Tiredness 
 Weakness 
 Jaundice 
 Yellow eyes 
 Yellow skin 
 Enlarged liver 
 Abnormal liver function test results 
 Swelling in feet 
 Weight gain due to water retention 
 Prolonged bleeding time. 
1.1.5.4. Treatment  
These are various sources for hepatotoxicity treatment mode these 
selected by consultation by physician about the treatment or change in 
treatment regimen. Treatment of hepatotoxicity has dependent upon 
causative agent, degree of liver dysfunction and age and general health of 
patient. Treatments for hepatotoxicity include: 
 Withdrawal of causative medication or removal from exposure to 
causative agent. 
 Regular monitoring of patient and review of liver function – where liver 
dysfunction is mild to moderate and liver function is improving. 
 Complete avoidance of alcohol and medication that may contribute to 
further liver damage. 
 N-Acetylcysteine is used for paracetamol toxicity. 
 Management of symptoms of liver damage. 
 Nutrition – with vitamin supplementation as required 
 Regular exercise inorder to maintain muscle mass. 
 Ursodeoxycholic acid. 
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 Management of pruritus 
 Cholestyramine 
 Antihistamines. 
 Management of ascites 
 Low sodium diet. 
 Diuretics – furosemide, spironolactone. 
 Removal of fluid via a needle in the abdomen – 
Paracentesis.   
 
 Portosytemic shunting. 
 
 Management of portal hypertension 
 Beta - blockers     
 Oesophageal variceal banding 
 Portocaval shunt 
 Management of acute liver failure due to hepatotoxicity 
 Supportive care always in intensive care unit – airway 
protection, fluid and electrolyte management. 
 
 Management of complications such as bleeding 
problems and hepatic encephalopathy.    
 
 Liver transplantation – for acute fulminant liver failure or end stage 
cirrhosis. 
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1.1.5.5. Hepatotoxins 
            Agents which cause liver injury are called as hepatotoxins34. 
                         Table.No:1:Types of Hepatotoxic Agents42 
 
                
I have selected paracetamol, ethanol and carbon tetrachloride to induce 
hepatotoxicity.  Liver injury caused by hepatotoxins such as carbon 
tetrachloride, ethanol and acetaminophen is characterized by varying degrees 
of hepatocyte degeneration and cell death by either apoptosis or by necrosis. 
Generation or formation of reactive intermediate metabolites from metabolism 
of hepatotoxins and occurrence of reactive oxygen species (ROS) in 
inflammatory reaction accounts for variety of Pathophysiological pathways 
resulting in cell death includes covalent binding, tangled cytosolic calcium 
homeostasis, GSH depletion, starting of mitochondrial permeability transition 
(MPT) and associated lipid peroxidation43. 
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a.Paracetamol induced hepatotoxicity 
Paracetamol (Acetaminophen), a widely used analgesic and antipyretic 
drug that produces acute liver damage in high doses.  Paracetamol related 
hepatotoxicity is now the most common cause of the potentially devastating 
clinical syndrome of acute liver failure in many western countries.44 Most such 
instances are the consequence of ingestion of large paracetamol overdoses 
often taken at a single time point with suicidal or parasuicidal intent45. Cases 
of severe hepatotoxicity high dose up to 10g daily or more cause other 
cytochrome P-450 enzyme inducing drugs46. 
Paracetamol induced hepatotoxicity is thought to be caused by N-
acetyl-p-benzoquinoneimine (NAPQI), a cytochrome P-450 mediated 
intermediate metabolite47. NAPQI can react with sulphydryl groups such as 
glutathione and protein thiols. The covalent bonding of NAPQI to cell proteins 
is considered the initial step in a chain eventually leading to cell necrosis48. It 
has been established that a hepatotoxic dose of paracetamol depletes 
endogenous glutathione level to below a threshold value (<20% of control), 
therefore permitting interaction of NAPQI with cell macromolecules49. 
i.Metabolic activation of acetaminophen 
Acetaminophen causes potentially fatal hepatic centrilobular necrosis if 
taken in overdose. It is metabolically activated through cytochrome P-450 
enzymes to reactive metabolite which depleted glutathione (GSH) and 
covalently bounds to protein. It shows that repletion of GSH prevented 
toxicity. Reactive metabolite was characterized to be N – acetyl – p – 
benzoquinone imine (NAPQI) 50. After high dose ingestion of acetaminophen 
total hepatic GSH is decreased by as much as 90% and as a result metabolite 
covalently binds to the cysteins groups on proteins forming acetaminophen 
protein adducts. This mechanism is shown below,  
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Figure.No:5: Schematic Representation of Metabolic activation of 
Acetaminophen Toxicity51 
 
 
Events of hepatocellular necrosis subsequent formation of 
acetaminophen protein molecule adducts are not fully understood. One of the 
mechanism of cell death and  formation of covalent bonding to critical cellular 
proteins lead to cell death and lysis. First major cellular targets have been 
initiated to formation of mitochondrial proteins with subsequent loss of energy 
synthesis as well as proteins involved in cellular ion control52. Blockage of 
mitochondrial ion concentration has to form a toxic mechanism involved in 
acetaminophen – mediated cell death.  These ion losses can subsequently 
increases the cytosolic ca2+  levels, lead to DNA strand breaks53. 
Oxidative stress is the one of important factor which will be  responsible for 
the development of acetaminophen toxicity. Under conditions of NAPQI 
formation after toxic acetaminophen dose, GSH concentrations are very low in 
the centrilobular cells and   major peroxide detoxification enzyme, GSH 
peroxidase was inhibited. When GSH levels are low, the metabolite fails to be 
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detoxified by conjugation; it accumulates and causes liver injury54. Lipid 
peroxidation resulting from oxidative stress contributes to the initiation and 
recently reported data suggest that acetaminophen hepatotoxicity is mediated 
by an initial metabolic oxidation, covalent bonding and subsequent activation 
of macrophages to form reactive oxygen and nitrogen species55. Protection 
against oxidation is provided by glutathione and by system of soluble and 
enzymatic defenses. 
Figure. No: 6: Schematic Representation Depicting Role Of Oxidative 
Stress In Acetaminophen Toxicity51 
     
   
          
Mitochondrial dysfunction is an important mechanism in 
acetaminophen induced toxicity. Mitochondrial permeability transition (MPT) 
occurs with the formation of superoxide and may be formation of superoxide 
radical may subsequent synthesis of  peroxynitrite and tyrosine 
nitration.Oxidants like peroxides and peroxynitrite, ca2+ and Pi promote onset 
of MPT, whereas Mg2+, ADP, low PH and high membrane potential imbalance 
onset of action.  Permeability change is associated with membrane 
depolarization, uncoupling of oxidative phosphorylation, releasing of 
intramitochondrial ions concentration, metabolic intermediates and 
mitochondrial oedema 
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Figure. No: 7 :Schematic Representation effect Of Mitochondrial 
Permeability Transition In Acetaminophen Toxicity51.
 
           
b.Ethanol induced hepatotoxicity 
Ethanol induces number of deleterious metabolic changes in liver. 
Intake of ethanol for long time leads to development of steatosis, alcoholic 
hepatitis and cirrhosis resulting in weight and volume changes56. About 80% 
of heavy drinkers had been reported to develop steatosis, 10-35% alcoholic 
hepatitis and approximately 10% liver cirrhosis57. 
i.Mechanism underlying Ethanol induced hepatotoxicity 
Alcohol consumption results in increase in release of endotoxin from 
gut bacteria and membrane permeability of gut to endotoxin or both. Females 
are more often sensitive to these changes. Blood endotoxin is elevated and 
enters liver where it is engulfed by Kupffer cells that become activated 
releasing TNF- alpha, PGE2 and free radical. Prostaglandins increase oxygen 
uptake and are responsible for hypermetabolic state in liver. Increase in 
oxygen demand leads to hypoxia of liver and on reperfusion alpha - 
hydroxyethyl free radicals are formed that leads to tissue damage in oxygen 
poor pericentral regions of liver lobule. Blocking of these events can be done 
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by sterilization of gut using antibiotics or destruction of Kupffer cells with 
Gdcl3 and thus prevents liver injury58. 
Figure. No:  8: Mechanism of ethanol induced hepatotoxicity59. 
 .  
        
c.CCL4 Induced hepatotoxicity 
Administration of carbon tetrachloride to rodents is a commonly used model to 
investigate mechanism of hepatic damage. Reactive free radicals induced by 
carbon tetrachloride are initiative for cell damage by two different mechanisms 
which include (1) binding to membrane proteins followed by (2) lipid 
peroxidation60. CCL4 has high lipid 6solubility so well distributed in body but 
produces toxic effects largely to liver and kidneys. Toxicity increased by 
agents that induce microsomal drug metabolizing enzymes and reduced by 
inhibitors of microsomal enzymes. 
i.Mechanism underlying CCL4 induced hepatotoxicity 
Microsomal mixed function oxidase system withdraws an electron from 
CCL4 leaving reactive trichloromethyl radical (CCL
*
3)
61 by action of 
microsomal cytochrome P-450 enzyme (CYP2E11). This highly reactive free 
radical suddenly reacts with molecular oxygen to form trichloro methyl peroxy 
radical (CCL3O2). Both trichloro and peroxy radical can bind to cellular 
proteins and lipids initiating lipid peroxidation and liver damage62. 
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Trichloromethyl free radical has life time of only about 100 microseconds and 
so has time to diffuse for only short distance within liver cell before 
undergoing secondary reactions. Secondary reactions are responsible for 
biochemical damage may be of different kinds which include: 
a) Oxidation of thiols to form disulphide bonds. 
b) Saturation of double bonds in lipids, nucleotides, proteins which results 
in covalent attachment of free radical group of those sites. 
c) Lipid peroxidation reaction where polyunsaturated membrane lipids are 
converted to peroxide derivative and finally to aldehydes and other 
products leading to further cascade of reaction resulting in irreversible 
membrane damage. 
Prolonged administration of ccl4 leads to cirrhosis and hepatic 
carcinoma61. 
1.1.6. Modern medicines for treatment of liver diseases 
Liver diseases can be treated using allopathic as well as by using herbal 
drugs. 
1.1.6.1. Hepatoprotective allopathic treatment 
Few modern medicines are available for treating liver diseases that includes: 
1) Ursodeoxycholic acid (Ursodiol) 
Ursodiol decreases intestinal absorption and suppresses hepatic 
synthesis and storage of cholesterol. It is mainly used in management 
of chronic hepatic diseases in humans. 
2) Penicillamine 
Penicillamine chelates several metals like copper, iron, lead and 
mercury forming stable water soluble complexes which are renally 
excreted. 
Other drugs: 
Antiviral medication such as alpha interferon, ribavirin, steroids, antibiotics 
etc. are also used in liver diseases63.Drugs like tricholinecitrate, 
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trithioparamethoxy phenyl propane, essential phospholipids, combination of 
drugs such as L-ornithine, L-aspartate and pancreatin, silymarin and 
Ursodeoxycholic acid are usually prescribed for hepatitis, cirrhosis and other 
liver diseases64. N-acetylcysteine is used in early phases of acetaminophen 
toxicity. L-carnitine is potentially valuable during valproate toxicity. 
Cholestyramine can be used to alleviate pruritus39. 
i.Disadvantages of allopathic drugs 
Side effects of many modern medicines are mostly alarming. Interactions, 
contra-interactions, side effects and toxicity of synthetic medicine vary from 
mild to severe that includes insomnia, vomiting, fatigue, dry mouth, diarrhea, 
constipation, dizziness, suicidal thought, depression, seizures, anemia, hair 
loss, high blood sugar, swelling, impotency, confusion, fainting and finally 
death65.Antibiotics usually cause stomach upset or allergic reactions. 
Interferon shows side effects as flu-like illness with fever and body aches63. 
1.1.6.2.Herbal hepatoprotective drug treatment 
A number of polyherbal preparations have been used in treating various liver 
disorders since ages. Some herbal formulations include: 
a) Liv-52: It is a non-toxic hepatoprotective drug from Himalaya Drug Co. 
Liv-52 can improve clinical parameters in patients having liver damage 
mainly in alcoholic liver damage. 
b) LIMARIN®: It has potent hepatoprotective and free radical scavenging 
(antioxidant) activity. It is derived from active extract of fruit of silybum 
marianum63. 
Some of the polyherbal formulations have been verified for 
hepatoprotective activity against chemical driven liver damage in 
experimental animals which include Liv52, Liv42, Jigrine, Koflet66, 
Cirrhitin, Livex and Hepatomed etc.  
1.1.6.2.1.Limitations of herbal preparations 
            Herbal- based preparations for treating liver disorders has been in use 
in India for long time and has been popularized worldwide by leading 
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pharmaceuticals. Despite of popularity of herbal medicines for liver diseases 
in particular, are still unacceptable treatment modalities for liver diseases. 
Limiting factors include: 
 Lack of standardization procedures of herbal preparations. 
 Lack of identification of active components and principles. 
 Lack of randomized controlled clinical trials (RCTs). 
 Lack of toxicological evaluation67. 
 Poor solubility. 
 Poor bioavailability. 
 Poor hepatic cell regeneration.  
i..Hepatoprotective activity of silymarin 
Mechanism of action of Silybin is complex and highly beneficial in protecting 
hepatocytes. It blocks penetration of various toxins into hepatocytes and thus 
prevents cell death. It protects liver from oxidative intracellular free radicals by 
increasing activity of enzyme superoxide dismutase and peroxidase as well as 
by increasing concentration of glutathione and activity of peroxidase. Silybin 
strengthens and stabilizes cell membranes, inhibits synthesis of 
prostaglandins associated with lipid peroxidation and promotes regeneration 
of liver through stimulation of protein synthesis and thus effects on production 
of new hepatocytes88.Silybin acts in four different ways: 
 Antioxidant, scavenger and regulator of intracellular content of 
glutathione. 
 Cell membrane stabilizer and permeability regulator that prevent 
hepatotoxic agents from entering hepatocytes. 
 Promoters of ribosomal RNA production, stimulating liver 
regulation. 
 Inhibitors of transformation of stellate hepatocytes into 
myofibroblasts- process which is responsible for deposition of collagen 
fibers leading to cirrhosis8 
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CHAPTER II 
                          2.LITERATURE REVIEW 
Afiwa Missebukpo,et,al (2010) 93 was investigated the hydro-alcoholic 
extract of Ixora coccinea (ICE) exhibit the anti-asthmatic activity in an 
ovalbumin (OVA) induced asthmatic rat model. These facts led us to examine 
their antioxidant activities. The free radical 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) scavenging activity and the intracellularly antioxidant activity of ICE 
were determined. The protective effect of ICE against 2,2′ azobis (2-
amidinopropane) hydrochloride (AAPH)-induced red blood cell lysis was also 
evaluated. It was found that ICE could scavenge DPPH with an IC50 of 283.3 
μg/ml and protected red blood cell against AAPH-induced hemolysis with an 
IC50 of 72.92 versus 52.08 μg/ml for ascorbic acid. Erythrocytes obtained 
from the ICE-administrated rats showed an enhanced resistance to 
hemolysis. In OVA-induced asthma, rats were sensitized and challenged with 
ovalbumin. The effect of ICE at 1500 mg/kg per os on malondialdehyde 
(MDA) production and lung catalase activity were determined. ICE 
significantly reduced the lipid peroxidation and enhanced catalase activity in 
lung (p < 0.05). In conclusion, the hydro-alcoholic extract of I. coccinea 
possesses an antioxidant activity and protective effect against free-radical-
induced hemolysis 
 
Prabu,et,al(2010) 94 reported the anti-diarrhoeal activity of aqueous extract 
of the leaves of Ixora coccinea against a castor oil induced diarrhoea model in 
rats. The gastrointestinal transit rate was expressed as the percentage of the 
longest distance which was traversed by the charcoal, divided by the total 
length of the small intestine. The weight and the volume of the intestinal 
content induced by castor oil were studied by the enteropooling method. 
Loperamide was used as a positive control. The plant-extract showed 
significant (P<0.001) inhibitor activity against castor oil induced diarrhoea and 
castor oil induced enteropooling in rats at the dose of 400 mg/kg. There was 
significant reduction in gastrointestinal motility by the charcoal meal test in 
rats. 
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Moni Rani,et,al (2008) 95 reported the anti-oxidant activity of  the methanol 
extract of Ixora coccinea L by DPPH free radical scavenging assay, reducing 
power and  total antioxidant capacity using phosphor molybdenum method. 
Preliminary phytochemical screening revealed that the extract of the leaf of 
Ixora coccinea possesses flavonoids, steroids and tannin materials. The 
methanolic extract showed significant activities in all antioxidant assays 
compared to the standard antioxidant in a dose dependent manner and 
remarkable activities to scavenge reactive oxygen species (ROS) may be 
attributed to the high amount of hydrophilic phenolics. In DPPH radical 
scavenging assay the IC50 value of the extract was found to be 100.53 μg/mL 
while ascorbic acid had the IC50 value 58.92 μg/mL. Thus Ixora coccinea 
extract showed strong reducing power and total antioxidant capacity. 
Latha,et,al (2010)96 reported the hepatoprotective activity in ethanolic 
extracts of three different plants Ixora  coccinea (IC), Rhinacanthus nasuta 
(RN), Spilanthes ciliata (SC) on the aflatoxin B1 (AFB1) –intoxicated livers of 
albino male Wistar rats. Biochemical parameters, including serum hepatic 
enzymes (glutamate oxaloacetate transaminase, glutamate pyruvate 
transaminase and alkaline phosphatase), were  studied. Pre-treatment of the 
rats with oral administration of these plant ethanolic extracts, prior to AFB1 
was found to provide significant protection against toxin induced liver damage, 
determined 72 hours after the AFB1 challenge (1.5 mg/kg, intraperitoneally) 
was evidenced by a significant lowering of the activity of the serum enzymes 
and enhanced hepatic reduced GSH status. Pathological examination of the 
liver tissues supported the biochemical findings. The three plant extracts, IC, 
RN and SC, showed significant anti-lipid peroxidant effects in vitro. 
Nagaraj,et,al (2011) 97 reported thesynthesis of gold nanoparticles in 
aqueous medium using leaf extracts of Ixora coccinea as reducing and 
stabilizing agent. On treating chloroauric acid solution with extract, rapid 
reduction of chloroaurate ions is observed leading to the formation of the 
highly stable gold nanoparticles in solution. The synthesized nanoparticles are 
confirmed  by colour changes and it has been characterized by UV-visible  
pectroscopy. Presence of this strong broad plasmon peak has been well 
documented for variousMe- NPs, with sizes ranging all the way from 2 to 100 
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nm. The morphology and size of the biologically synthesized gold 
nanoparticles were determined using TEM. The images clearly showed that 
the average size of the nanotriangles is about 200 nm, while, the spherical 
like particles show very small size about 5-10 nm. This study also showed that 
gold nanoparticles with antibiotic show more inhibitory zones than compared 
to the standard antibiotics. 
        Panikar,et,al(1998)98 reported theantitumour activity of  Ixora coccinea 
L. (Rubiaceae) leafs was studied in  comparison to intraperitoneally 
transplanted Dalton's  lymphoma (ascitic and solid tumours) and Ehrlich 
ascites carcinoma (EAC) tumours in mice. Intraperitoneal administration of 
200 mg/kg of the active fraction (AF) of the I. coccinea leaf increased the life-
span of DLA and EAC ascitic tumour-bearing mice by 113 and 68%, 
respectively. The AF showed less activity against solid tumours (DLA) as 
compared to ascitic tumours. The same active fraction showed  50% 
cytotoxicity to DLA, EAC and Sarcoma-180 (S-  180) cells in vitro at 
concentrations of 18, 60 and 25  μg/ml, respectively. It was not toxic to normal  
lymphocytes, whereas it was toxic to transformed  lymphocytes from 
leukaemic patients, acute  lymphoblastic leukaemia (ALL) and chronic 
myelogenous leukaemia (CML) and K-562 suspension  cell cultures. The AF 
inhibited tritiated thymidine incorporation in cellular DNA. Thus the Thus the 
anti-tumor activity of Ixora coccinea plant was proved. 
Yasmeen,et,al(2011)99 reported the hypoglycaemic and  the 
hypolipidaemic activity of the aqueous extract of  the leaves of Ixora Coccinea 
Linn in alloxan induced  diabetic albino rats. The aqueous extract of leaves of  
Ixora Coccinea showed significant reduction (p<0.01) in the blood glucose 
levels and the serum lipid profile  levels, with 400 mg/kg of body weight in the 
alloxan induced diabetic rats as compared to the controls. 
Elumalai,et,al(2012)100 was studied the phytochemical and ethano 
pharmacological profile of Ixora coccinea and he reported it have anti-
oxidant,anti-inflamatory and antidiabetic activity. 
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                                                         CHAPTER III 
3. AIM AND OBJECTIVES 
 Plants that cure liver diseases so considerable interest has developed 
in the examination of these numerous plants remedies which are useful in 
liver diseases. So it is necessary to find new drugs of importance in hepato 
protective activity with fewer side effects. Moreover it is necessary to produce 
scientific validation to drugs of herbal origin in common use under Ayurvedic 
Siddha Unani systems of medicine. Why I have to select this particular 
disease is few effective drugs available for modern therapy, it produce side 
effect during the treatment is worse than the condition of liver damage 
Phytochemical investigation will be a useful tool for the identification 
and authentication of the plant for industrial and further research purpose. 
Total phenol content of a tested material is related to the antioxidant activity. 
Antioxidants, which can scavenge free radicals, have an important role in 
pharmacological systems. Antioxidants are emerging as prophylactic and 
therapeutic agents. Hence, antioxidant was also evaluated for the potent 
extract. 
And now I have undertaken the study of evaluation of anti-oxidant and 
hepatoprotective activity of ixorea coccinea leaf extracts by various 
hepatotoxin induced albino rat models  
 To select plant based on their ethno medical uses and preparation 
of their extracts.  
 To screen phytochemical profile. 
 To screen the selected extract for antioxidant using various in vitro 
methods  
 To screen the potent plant extract for their in vivo hepatoprotective 
activities 
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                                       CHAPTER IV 
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CHAPTER V 
5.PLANT PROFILE 
IXORA  COCCINEA 
101
 
                     Figure. No:9:  ixora coccinea palnt 
 
                     5.1.   Taxonomical classification 102     
Table.No:2:Taxonomical classification of Ixora coccinea 
Kingdom Plantae 
Subkingdom Tracheobionta 
Division Magnoliophyta 
Class Magnoliopsida 
Subclass Asteridae 
Order Rubiales 
Family Rubiaceae 
Genus Ixora 
Species Coccinea 
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 5.2.Vernacular names of Ixora coccinea103 
Table.No:3:Vernacular names of Ixora coccinea103 
 
 
 
 
 
 
 
 
 
5.3.Distribution and habitat104 
 Ixora coccinea is a common leafing shrub native to Southern India and Sri 
Lanka and widely cultivated in Indonesia, Malaysia, the Philippines, Vietnam, 
Cambodia, Laos and Thailand. It has become one of the most popular leafing 
shrubs in South Florida – USA gardens and landscapes. It grows in tropical 
areas with in medium annual rainfall in well drained soils. 
5.4.Description 
Ixora coccinea is a low-growing tropical shrub notable for its bright 
coloured leafs which are composed of many small blooms massed together 
into dense, flat-topped leaf heads. Ixora coccinea is one of the few 
Ixora species that make good indoor plants along with several kinds 
developed from it. 
It takes up to five years for Ixora coccinea to grow to its maximum height 
of about 1.2m (4 feet). It is a much-branching shrub, with leathery, shiny, 
pointed oblong leaves up to 10cm (4 inch) long and 5cm (2 inch) wide 
arranged in pairs or whorls of three or more in 1-2cm (0.4-0.8 inch) long 
stalks. Leaf color is dark green, often bronzish when the leaves are new. 
Tubular leafs, which are up to 5cm (2 inch) long and fiery red, open at the 
month into four petals arranged in the form of a cross about a centimeter (0.4 
inch) wide. The entire leaf head has a diameter of 8-12cm (3-5 inch). Normal 
leafing period is summer, but occasional leafs also appear in the autumn. 
English Ixora 
Hindi Rugmini 
Tamil Vedchi 
Bengali Rangan 
Malayalam Chethi 
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Various kind of Ixora which have  Ixora coccinea as a parent produce 
differently coloured blooms, chiefly in shade of orange, yellow and pink, as 
well as red. 
5.5.Propagation 
Propagate Ixora coccinea from stem cuttings 5-8cm (2-3 inch) long taken 
in spring. Trim each cutting immediately below a leaf, remove that leaf and dip 
the cut end in hormone rooting powder. Plant the cutting in a 5-8cm (2-3 inch) 
pot containing a moistened equal-parts mixture of peat moss and coarse sand 
or perlite. Enclose the whole in a plastic bag or propagating case and stand it 
in bright filtered light at a temperature of 21-27°C (70-81°F). When the cutting 
has rooted – probably in four to six weeks – uncover it gradually over a two or 
three week’s period in order to acclimatize the new plant to the less humid 
atmosphere of the room. When the new plant is fully uncovered, begin to 
water moderately (allowing a couple of centimeters (0.4-0.8 inch) or so of the 
potting mixture to dry out between watering again) and apply standard liquid 
fertilizer once every two weeks. About three months after the start of the 
propagation move the new plant into a slightly bigger pot of the recommended 
potting mixture for adult plants and treat it as mature. 
5.6.Uses105  
   It is primarily ornamental plant. Cut specimens are long lasting and are often 
used in floral arrangements. It is sometimes used as a hedge. In tropical Asia 
the leafs, bark and leaves of this plant are used in traditional medicine. 
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CHAPTER VI 
6. MATERIALS AND METHODS 
6.1.Collection and authentication of plant 
Ixora coccinea leaf was procured from the Botany Central council for 
Research in Ayurvedia and Siddha Govt of India.(Certificate 
No:UWAU/350/16) The dried leafs are authenticated by Chelladurai.V 
research officer Botany Central council for Research in Ayurved and Siddha 
Govt of India. 
6.2.Extraction Procedure: 
i.Preparation of Ixora coccinea leaf extract106 
The leaf were initially separated from the main plants body and rinsed 
with distilled water and shade dried and then homogenized into fine powder 
and stored in air tight bottles. A total of 10 g of leaf air dried powder was 
weighed and was placed in 100 mL of organic solvents (methanol and 
ethanol) in a conical flask and then kept in a rotary shaker at 190-220 rpm for 
24 h. And then it was filtered with the help of muslin cloth and centrifuged at 
10 000 rpm for 5 min. The supernatant was collected and the solvent was 
evaporated by solvent distillation apparatus to make the final volume of one-
fourth of the original volume, giving a concentration of 40 mg/mL. It was 
stored at 40 °C in air tight bottles for further studies.  
6.3.Phyto chemical screening107-108 
The plant may be containing the following compound such as 
carbohydrate, protein, and lipids. That is utilized as food by man. It also 
contains the compound like. Tannins, glycosides, alkaloids. Volatiles oils. The 
compound that is responsible for lots of medicinal properties  
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6.3.1.Test for carbohydrates  
  6.3.1.1..Molisch test 
                      The sample powdered was added with 1 ml of alpha napthol 
solution along with conc Sulphuric acid solution in the test tube reddish 
colour was produced at the junction between 2 liquid  
 6.3.1.2..Fehling test. 
  To the sample powder was added with both Fehling A and 
Fehling B solution and placed in the water bath for a sufficient time. 
This shows the brick red colour.  
 6.3.1.3..Benedicts test. 
  To the sample powder add 8 drops of benedict’s reagents and 
Boil the sample vigorously for 5 min it shows the red ppt. 
6.3.2.Test for alkaloids 
 To the small of stored powder (sample) was taken and add few drops 
of hydrochloric acid and filtered. The filtered was tested with various 
alkaloid agents. 
 6.3.2.1.Mayer’s reagents 
  To a small of above filter add small quantity of Mayer’s reagent 
to form cream precipitate. 
 6.3.2.2..Dragendorff’s reagents 
  From the above filter add small amount of Dragendorffs 
reagents it forms a orange brown precipitate.  
6.3.3.Test for flavonoids 
  To the filter of the plant extract add 5 ml of dilute ammonia 
solution and followed by the addition of concentrated sulphuric acid. It 
forms a yellow colour.  
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6.3.4.Test for steroids. 
6.3.4.1.Salkowski test 
                      Few amount of plant extract was mixed with chloroform and the 
same volume of sulphuric acid is added on it. Cherry red colour was 
obtained in the chloroform layer. 
6.3.4.2.Libbbermann burchatd test: 
  The extract is dissolved in 2 ml of chloroform 10 drops of acetic 
acid and conc. Sulphuric acid were added. Now the solution becomes 
reddish colour then it turns to bluish green colour. 
6.3.5.Test for tannins. 
 From few amount of plant extract is treated with vanillin hydrochloric 
acid reagent. It forms, pink or red colour due to the formation of 
phloroglucinol, 
 6.3.6.Test for protein. 
 6.3.6.1..Millon’s reagents. 
  Millon’s reagents (mercuric nitrate in nitric acid containing a 
trace of nitrous acid) usually yields a white precipitate on addition to a 
protein solution which turns red on heating.  
 6.3.6.2.Ninhydrin Test. 
   From the sample solution add 2 drops a freshly prepared 
0.2% ninhydrine reagent was added to the extract and heating. 
Development of blue colour may indicate the presence of peptide, 
amino acid (PROTEIN). 
6.3.7.Test for glycosides 
 6.3.7.1.Keller- killani test. 
  From the small quantity of small powder acetic acid was 
dissolved and adds few drops of ferric chloride and transferred to the 
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surface of conc Sulphuric acid. At the junction, reddish brown colour 
was formed,  
6.3.8.Test for saponins. 
 6.3.8.1.Foam test 
 1 ml of extract solution is diluted separately with distilled water to 20 ml 
and shaken in a graduated cylinder for 15 minutes. A 1 cm layer of foam 
indicates the presence of Saponins.  
6.3.9.Test for Terpenoids: 
          About 0.5 g of plant extract in separate test tube was taken with 2 ml of 
chloroform; 5 ml of concentrated sulphuric acid was carefully added to form a 
layer and observed for presence of reddish brown color interface to show 
positive results for the presence of terpenoid. 
 
6.4. In vitro antioxidant activities 
6.4.1. Superoxide radical scavenging activity109  
Principle: 
The superoxide anion radical scavenging activity was 
determined by nitro blue tetrazolium (NBT) reduction method of Mc Cord and 
Fridovich (1969). The assay is based on the ability of drug to inhibit the 
reduction of nitro blue tetrazolium (NBT) by Superoxide, which is generated 
by the reaction of photo reduction of riboflavin within the system. The 
superoxide radical thus generated reduce the NBT to a blue colored complex. 
i.Reagents 
 Nitro blue tetrazolium (NBT)   -  1.5nm  (12.3mg/10ml) 
 Riboflavin            -   0.12µm  (4.5mg/100ml) 
 NaCN/EDTA            -   0.0015% NaCN in 0.1M EDTA 
 Phosphate buffer          -    0.06M  ( pH 7.8 ) 
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ii.Procedure: 
The reaction mixture contained EDTA (0.1 M), 0.3mM NaCN, Riboflavin 
(0.12mM), NBT (1.5 n moles), Phosphate buffer (67mM, pH 7.8) and various 
concentrations of the seed oil extract in a final volume of 3ml. The tubes were 
illuminated under incandescent lamp for 15min. The optical density at 560 nm 
was measured before and after illumination. The inhibition of superoxide 
radical generation was determined by comparing the absorbance values of 
the control with that of seed oil extract and fraction-IV. Vitamin C was used as 
positive control. The concentration of fraction-IV required to scavenge 50% 
superoxide anion (IC50 value) was then calculated.   
iii.calculation      
  % inhibition   =        × 100 
6.4.2. DPPH radical reducing activity 110: 
i.Principle 
It is a rapid and simple method to measure antioxidant capacity. It 
involves the use of free radical, DPPH (2, 2- Diphenyl - 1- picryl hydrazyl) 
(Aquino et al, 2001). The odd electron in the DPPH free radical gives a strong 
absorption maximum at 517nm and is purple in color. The color turns from 
purple to yellow when the odd electron of DPPH radical becomes paired with 
hydrogen from a free radical scavenging antioxidant to form the reduced 
DPPH-H. The resulting decolourisation is stochiometric with respect to the 
number of electrons captured. 
i.reagent 
 DPPH  -   3mg in 25ml methanol (stored in dark bottle) 
 Methanol        
ii.Procedure 
Freshly prepared DPPH (187 µl) was taken in different test tubes 
protected from sunlight. To this solution added different concentrations (0, 25, 
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50, 75,100,150,200µg/ml) of seed oil extract and fraction-IV. The volume was 
made up to 1ml with methanol. Keep the tubes in dark and after 20 min 
absorbance was measured at 515nm. Methanol was used as blank and 
vitamin C was used as positive control. The concentration of test materials to 
scavenge 50% DPPH radical (IC50 value) was calculated from the graph 
plotted with % inhibition against Concentration. 
iii.Calculation      
    % inhibition   =       × 100 
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6.5.Pharmacological screening 
6.5.1.Acute toxicity study111 
Experimental Protocol 
Guideline   :  OECD – 423 
CPCSEA Reg. No  : KU/IAEC/M.pharm/172 
Test    : Limit test 
Species   :   Rattus norvegicus 
Strain    :  Albino Wistar rats 
Number of animals  :  05 
Sex    :  Male/female 
Initial dose   : 5mg/kg 
Route of administration :  Oral 
Duration   :  3hr close observation, followed by 14 days 
observation 
Others   :  Body weight, water intake, mortality status 
Parameters   :    CNS, ANS and behavioral changes  
Blood collection  :   Not needed 
Sacrifice   :  On day 14 after oral administration 
 
 
 
 
 
                                                                                       
 
 Page 46 
 
Table.No:4:Experimental designs 
 
 
 
                         
 
 
i.Study design 
Test animal – 6-8weeks old Adult Wistar rats of male and female, nulliparous 
and non-pregnant animals were obtained from centralized animal house from 
lab and acclimatized to holding for 1 week prior dosing. 
ii.Housing conditions 
Temperature – The experimental animal room temperature maintained at 
22°C±3°C OECD guideline-423, 2001. These ranges are designed to allow 
homeotherms to maintain metabolic rate or to be within their thermo neutral 
zones. Because, temperature below the recommended range leads to 
increased food intake, increased energy expenditure but decrease in 
efficiency. In contrast, temperature above the recommended range leads to 
decreased food intake, decreased weight and decreased energy expenditure. 
Toxicity can vary with temperature might increase with linearity with 
temperature. 
Humidity – The relative humidity maintained at 40%-60% preferably not 
exceeds 70% (OECD-423, 2001).The relative humidity below the 
recommended range can develop lesions such as ring tail and food 
consumption may be increased. 
Light – 12-12 hours, Light/dark cycle. Appropriate lighting and light cycle play 
a key role in maintaining the physiology and the behavior rat. Light provided 
Group Dose(mg/kg) 
Group I 5 
Group II 50 
Group III 300 
Group IV 2000 
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for adequate vision and for neuroendocrine regulation of diurnal and circadian 
cycles (CPCSEA guidelines for laboratory animal facility 2003). 
Light intensity – The light intensity maintained at 325 lux approximately 1m 
above the floor. Consideration of variations in light intensity, for the 
arrangement of animals on cage rack for toxicology study is necessary.  
Caging – Polypropylene cages with solid bottom and walls. Lids made up of 
stainless steel grill capable of holding of both feed and water. 
ii.Feeding condition – Sterile laboratory feed (ad libitum) and RO water 
bottles daily. 
iii.Feed – Brown colored chow diet 
iv.Drug administration – Animals were fasted for 12hour prior to dosing on 
day 0. Treatment rats were dosed by oral gavages, using a curved and ball 
tipped stainless steel feeding needle, with 20% gum acacia solution.  
v.Clinical observations – All rats were monitored continuously for 4 hour 
after dosing for signs of toxicity. For the remainder of the 14 days study 
period, animals were monitored and any additional behavioral or clinical signs 
of toxicity. Animal’s body weight was measured prior to dosing and on days 7 
and 14.On all animals were killed and at the end of the study LD50 value was 
established. Clinical observations and gross pathological examination was 
carried out. 
6.5.2. Evaluvation of hepatoprotective activity 
6.5.2.1.Paracetamol induced liver toxicity 
i.Animals 
Healthy adult  male Albino rats (120-200 gram body weight) were 
procured and randomly assigned to 5 groups, each containing 6 animals in 
polypropylene cages layered with husk and maintained in a controlled room at 
a temperature (22±3°C) and light (12 hours light/dark cycle). Animals were 
allowed free access to water and standard pellet diet. Animals were cared in 
accordance with the “Guide for the care and use of laboratory animals” and 
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study was conducted in accordance with CPCSEA. All animal experiments 
were conducted during the present study got prior permission from 
Institutional Animal Ethics Committee (IAEC approved) and following the 
guidelines of Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA) constituted by the Animal Welfare 
Division, Government of India (No:- IAE 1012/c/07/  CPCSEA-Corres-2013- 
ii.Methodology112: 
The paracetamol suspension was freshly prepared at a dose of 2 
gm/kg of paracetamol in 1ml of distilled water111. Animals group received a 
single dose of paracetamol 2gm /kg through oral route for 7 day. Animals 
were allowed to develop hepatotoxicity, which was identified by biomarkers. 
Hepatotoxicity induced animals were selected for 28 days treatment. (Table 2)  
Table.No:5:Experimental design of paracetamol induced liver 
toxicity 
Group Treatment  
1 
2gm/kg of Paracetamol in 1ml of distilled water to induce hepatotoxicity and 
received no other treatment which is severed as paracetamol control. 
2 
2gm/kg of Paracetamol in 1ml of distilled water. After hepatotoxin induction, 
animals were treated orally with pure silymarin(100 mg/kg of body weight) 
3 
2gm/kg of Paracetamol in 1ml of distilled water. After hepatotoxin induction, 
animals were treated orally with prepared extract (100 mg/kg of body 
weight) 
4 
2gm/kg of Paracetamol in 1ml of distilled water. After hepatotoxin induction, 
animals were treated orally with prepared extract  (200 mg/kg of body 
weight) 
5 
2gm/kg of Paracetamol in 1ml of distilled water. After hepatotoxin induction, 
animals were treated orally with prepared extract  (400 mg/kg of body 
weight) 
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6.5.2.2.Evaluation of hepatoprotective efficacy: 
 Efficacy of the extract was assessed using biochemical marker 
enzymes such as, 
 SGPT. 
 SGOT. 
 ALP (Alkaline Phosphatase). 
  Total Protein. 
 Total Bilirubin. 
 Change in body weight. 
 
6.5.2.3.Sample collection and biochemical assay: 
 The blood samples obtained were collected into plain sample 
tubes and centrifuged at 2000 rpm for 5 minutes to separate serum. Serum 
was carefully collected and kept in eppendrof tubes for the determination of 
the biochemical parameters. 
6.5.2.4.Assessment of serum marker enzymes: 
                    Serum level of SGPT and SGOT: These are the potential 
biomarkers of hepatic injury and were estimated using a commercial kit 
(Medsource Ozone Biomedicals Pvt. Ltd) (Reitman’s and Frankel, 1957). 
Serum total protein (T. Protein was determined using the method Lowery et al 
1951). Serum total bilirubin (T. BIL) was determined using the method (Mallay 
et al 1937). Alkaline phosphatase (ALP) was determined using the method 
(king et al 1954), were assayed using standard Diagnostic kits at Benghazi 
medical center. 
6.5.2.5.Change in Body Weight:  
Animal body weight was measured weekly once from the starting day 
to end of the study in paracetamol, ccl4 and ethanol induced models. 
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6.5.2.6.Serum enzyme parameters 
a.Alanine transaminase (ALT)113 
i.Principle of Procedure 
            ALT catalyzes the transamination of L-Alanine to α-Ketoglutarate (α-
KG), forming L-Glutamate and Pyruvate. The Pyruvate formed is reduced to 
Lactate by Lactate Dehydrogenase (LDH) with simultaneous oxidation of 
reduced Nicotinamide-Adenine Dinucleotide (NADH). The change in 
absorbance is measured using a dichromatic (340, 700 nm) rate technique. 
          
 L-Alanine + α-KG    L-Glutamate + Pyruvate 
            P5P, Tris, pH 7.4 
       
            LDH 
  Pyruvate + NADH + H+                         Lactate + NAD+ 
 
ii.Summary 
The ALT method is an adaptation of the recommended procedure of 
the IFCC as described by Bergmeyer118. The procedure is based on the 
principles outlined by Wroblewski and LaDue but is modified to contain 
pyridoxal-5-phosphate (P5P) as an activator and to replace phosphate buffer 
with tris (hydroxymethyl) amino methane. Quantitation of ALT is a useful 
parameter in evaluating liver function. Significant elevations of ALT are found 
in diseases of the liver, such as hepatitis, necrosis, jaundice and cirrhosis. 
ALT levels can be elevated even before clinical jaundice appears. 
b.Aspartate transaminase (AST) 
i.Principle of Procedure114 
 AST catalyzes the transamination from L-Aspartate to α-
Ketoglutarate, forming L-Glutamate and Oxaloacetate. The Oxaloacetate 
formed is reduced to malate by Malate Dehydrogenase (MDH) with 
simultaneous oxidation of reduced Nicotinamide Adenine Dinucleotide 
(NADH). The change in absorbance with time due to the conversion of NADH 
                                                                                       
 
 Page 51 
 
to NAD is directly proportional to the AST activity and is measured using a bi 
chromatic (340, 700 nm) rate technique. 
AST 
L-Aspartate + α-Ketoglutarate                  L- Glutamate + Oxaloacetate 
 
            
MDH 
Oxaloacetate + NADH                           Malate + NAD 
                                                        
ii.Summary 
 The AST method is an adaptation of the methodology 
recommended by the International Federation of Clinical Chemistry (IFCC). 
The method uses the coenzyme Pyridoxal-5-Phosphate (P5P) to activate the 
apoenzyme and lactic acid Dehydrogenase (LDH) to eliminate pyruvate 
interference. AST levels are 10-200 fold elevated in patients with acute 
hepatic necrosis, viral hepatitis and drug induced poisoning. SGOT levels are 
also elevated 10 fold in patients with post hepatic jaundice, intra hepatic 
cholestasis and less than 10 fold in alcoholic and hepatic steatosis. 
c.Alkaline phosphatase (ALP) 
i.Principle of Procedure115 
  ALP catalyzes the transphosphorylation of p-
nitrophenylphosphate (p-NPP) to p-nitro phenol (p-NP) in the presence of the 
transphosphorylating buffer, 2amino-2-methyl-1-propanol (AMP). The reaction 
is enhanced through the use of magnesium and zinc ions. The change in 
absorbance at 405 nm due to the formation of p-NP is directly proportional to 
the ALP activity, since other reactants are present in non-rate limiting 
quantities and is measured using a bichromatic (405, 510 nm) rate technique. 
                                                                  ALP  
  P-NPP + AMP      p-NP + AMP + PO4 
    Ph 10.35 Mg/Zn 
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ii.Summary 
 Measurements of ALP are used in the investigation of 
hepatobiliary and bone disease119. The ALP method is based on a procedure 
published by Bowers and McComb and more recently reviewed by Rej. This 
method responds to all ALP isoenzymes in human serum. Marked increase of 
ALP is seen in obstructive jaundice and biliary cirrhosis. 
6.5.8.Histopathology Study116 
 Rats from all the treatment groups and control groups were euthanized on 
the day 7. After gross observation, liver was collected and fixed in 10% 
Neutral Buffer Formalin. 
 Trimming: Tissues were trimmed from all the lobes of liver. 
 Processing: Processing is done with the help of Automated Tissue 
Processor (ATP) (Leica ASP 300) for 16 hours. 
 Embedding: Processed tissues were embedded in paraffin with the help 
of paraffin embedding station (Leica EG 1150 H). 
 Sectioning: Initially blocks were trimmed at 25 microns and then 
sectioned at 4 microns with the help of semi-automatic Microtome (Leica 
RM 2245). 
 Staining: Slides were stained by H&E stain at Multistainer (Leica ST 
5020). 
 All the H&E stained slides were observed for pathological findings.  
6.5.9.Statistical analysis: 
N = 6, Values are Mean±SEM calculated using One way ANOVA 
followed by Tukey’s multiple comparison test, *P<0.05 and **P<0.001 
compared with Toxic treated group; **P<0.05 compared with vehicle treated 
group; # P<0.01. 
 
 
 
 
                                                                                       
 
 Page 53 
 
                                                 CHAPTERVII 
7.  RESULTS  AND CONCLUSION 
7.1.Soxhlet Extraction of Ixora coccinea leaf Extract (ICLE) 
The percentage yield of the ICLE in ethanol by cold maceration was found to 
be 2.93%w/w. 
Table.No:6:Extraction of Ixora coccinea leaf Extract (ICLE) 
7.2.Preliminary phyto chemical screening. 
 Ixora coccinea leaf extracts (ICLE) was subjected various chemical 
tested as per the standard methods for the identification of the various 
constituentsif this phyto chemical analysis is listed below. 
7.2.1Test for carbohydrates  
 i.Molisch test 
  No reddish colour was produced at the junction between 2 liquid 
it indicate the absence of carbohydrates 
 ii.Fehling test. 
  This shows the blue colour. It indicate the absence of 
carbohydrates 
 iii.Benedicts test. 
  shows the yellow ppt. It indicate the absence of carbohydrates 
 
 
Plant Part 
used 
Method of 
Extraction 
Solvents Percentage 
Yield (%W/V) 
Ixora 
coccinea  
leaf Maceration Ethanol 
(95%) 
2.93 
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7.2.2.Test for alkaloids 
i..Mayer’s reagents 
  It form cream precipitate. It indicate the absence of alkaloid 
ii.Dragendorff’s reagents 
  It forms a orange brown precipitate. It indicate the absence of 
alkaloid 
7.2..3.Test for flavonoids 
  It forms a yellow colour. It indicates the presence of flavanoid 
7.2.4.Test for steroids. 
i.Salkowski test 
.                     Cherry red colour was obtained in the chloroform layer. It 
indicate the absence of steroid 
ii.Libbbermann burchatd test: 
  solution becomes reddish colour then it turns to bluish green 
colour. It indicate the absence of steroid 
7.2.5.Test for tannins. 
 It forms, pink or red colour due to the formation of phloroglucinol, It 
indicate the absence of tannins 
7.2.6.Test for protein. 
 I.Millon’s reagents. 
  solution which turns red on heating. It indicates the presence of 
protiens 
            II.Ninhydrin Test. 
   Development of blue colour may indicate the presence of 
peptide, amino acid (PROTEIN). 
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7.2.7.Test for glycosides 
          I..Keller- killani test. 
                      It form redish color It indicate the absence of glycosides 
 7.2.8.Test for saponins. 
 I.Foam test 
 A 1 cm layer of foam indicates the presence of Saponins. 
7.2.9 Test for terpinoid 
                     observed for presence of reddish brown color interface to show 
positive       results for the presence of terpenoid. 
 
Table.NO:7:Qualitative phyto chemical screening of Ixora coccinea leaf 
extract (ICLE) 
PLANT 
CONSTITUENT 
INFERENCE 
Ethanol Extract 
Carbohydrate - 
Alkaloids - 
Flavonoids + 
Proteins and 
amino acids 
+ 
Glycosides - 
fixed oil - 
Terpenoids + 
Volatile oil - 
Tannins - 
“+” Presence, “-” Absence. 
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7.2.In vitro antioxidant activities 
7.2.1.Effect of on ixora coccinea leaf extract (ICLE) on superoxide 
radical scavenging activity 
Superoxide generated in the photo reduction of viaminC was effectively 
inhibited by the addition of varying concentrations (0-12 L/ml) of extract table 
8. The concentration of the ICLE needed to scavenge 50% superoxide anion 
(IC50) was found to be 11 g/ml (figure 13) Vitamin C which was used as a 
positive control had an IC50 value of 4.5 g/ml. 
Table.No:8:Effect of ICLE on superoxide in vitro radical scavenging 
activity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results are mean ± SD of three individual experiments 
 
 
Concentration 
(µg/ml) 
Absorbance 
Percentage 
inhibition 
Ethanol 
Extract 
Vitamin C 
Ethanol 
Extract  
Vitamin C 
0 0.78±0.11 0.78±1.33 0 0 
2 0.03±0.1 0.24±0.09 5.5±1.2 33.11±1.7 
4 0.09±0.2 0.37±0.12 13.5±2.1 
46.56±0.9
8 
6 0.20±0.30 0.42±0.32 25±3.6 
56.98±1.8
7 
8 0.27±1.1 0.52±0.14 33.19±4.2 65.18±2.9 
10 0.36±1.2 0.62±015 44.32±4.8 
68.54±1.3
5 
12 0.41±0.6 0.69±0.72 52.34±3.8 75.2±1.89 
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Figure. No:10: Superoxide radical reducing activity of ICLE and 
vitaminC 
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7.2.2.Effect of ixora coccinea leaf extract (ICLE) on DPPH 
radical reducing activity 
The DPPH radical was effectively scavenged by seed oil extract and Fraction- 
IV. A dose dependent reduction of was observed within the range of 
concentrations (0-100g/ml) of reaction system (Fig.14). The IC50 value of 
ICLE was found to be 110g/ml (Table.9). Vitamin C which was used as the 
positive control exhibited an IC50 value of 21.6 g/ml. 
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   Table.No:9:Study of in vitro DPPH Radical Scavenging Activity of  
ICLE 
 
  
 
Results are mean ± SD of three individual experiments. 
Concentration 
(µL/ml) 
Absorbance Percentage Inhibition 
 
Ethanol 
extract  
 
Vitamin C 
Ethanol 
Extract 
Vitamin C 
1 0.0691±0.12 0.591±0.23 0.21±1.2 15.8±1.23 
10 0.686±0.14 0.231±0.68 2.33±0.22 29.9±1.45 
20 0.665±2.5 0.341±1.5 5.1±1.22 49±1.63 
30 0.640±2.3 0.231±1.23 8.9±1.5 67.8±3.76 
40 0.59±1.56 0.22±1.85 13.5±6.5 87.3±4.56 
50 0.57±2.3 0.132±1.44 18.6±4.22 97.2±7.6 
60 0.53±.05 0.062±1.56 24.5±.3.89 96.1±5.67 
70 0.501±0.51 0.059±1.23 28.9±2.3 96.2±7.89 
80 0.472±2.5 0.052±2.56 33.4±0.45 96.2±1.23 
90 0.0.437±1.02 0.04±0.06 38.9±1.23 97.5±1.96 
1OO 0.407±3.8 0.03±0.03 42.1±3.4 97.6±3.45 
120 0.331±5.6 0.02±0.01 53.1±1.56 98.3.6.56 
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Figure. No:11: DPPH radical reducing activity of ICLE and 
vitaminC. 
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7.3 Pharmacological study 
 
7.3.1.Acute toxicity studies 
         Acute toxicity studies on the sd rats show no mortality at adose of 
2000mg/kg of ICLE during a time period of 14 days.during the study , no 
noticeable were seen in the rats . this help to predict that it does not contain 
any type of toxicity and it is full safe . so 200mg/kg between (1/10th dose) of 
ethanol extract were selected of that dose for the further study 
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7.4. Hepatoprotective activity 
7.4.1. Effect of ICLE on SGPT concentration in paracetamol induced model 
The results of biochemical parameters revealed to the alteration of enzyme 
levels in paracetamol treated group indicating that paracetamol induces 
damage to the liver. Table 10 shows that CCl4 causes significant increase in 
SGPT level from control 93.22 ±1.22 IU/L to 157.22±0.16 IU/L after 
paracetaml intoxication. Administration of ICLE  200mg/kg and 400 mg/kg in 
paracetamol intoxicated rats caused reduction in SGOT level to 127.22±0.21 
and 113.11±1.85IU/L respectively  
  Table.No:10:Effect of ICLE on SGPT concentration in paracetamol 
induced model 
 
.Value expressed as Mean ±SEM; Number of animals in each group 
=6.*P˂0.0001 
 
 
Treatment 
Dose 
mg/kg 
SGPT 
(IU/L) 
Control - 93.22±1.22 
Toxic control 2 gm/kg 157.22±0.16 
               Standard 100mg/kg 110.22±0.19 
Ethanol Extract  200 mg/kg 127.22±0.21 
Ethanol Extract  400 mg/kg 113.11±1.85 
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Figure .NO:12:Effect of ICLE on SGPT concentration in paracetamol 
induced model 
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7.4.2.Effect of ICLE on SGOT concentration in paracetamol induced 
model 
    Table 11 shows that paracetamol affect significant increase in SGPT 
concentration from control 45.46 ±0.24 IU/L to 70.05 ± 0.2 IU/L after 
paractamol intoxication. Administration of ICLE 200 mg/kg and 400 mg/kg in 
paracetamol intoxicated rats caused reduction in SGOT level up to  
56.21±0.2IU/L and 50.12±2.2 IU/L respectively (P<0.001). The extract in 
Standard dose of silymarine (100mg/kg) animals does not cause any 
significant changes in SGOT level  
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Table.No:11:Effect of ICLE on SGOT concentration in paracetamol induced 
model 
 
 
 
 
 
 
 
 
 
           Values expressed as Mean ±SEM; Number of animals in each group 
=6.  *P˂0.0001 
Figure .NO:13: Effect of ICLE on SGOT concentration in paracetamol 
induced model 
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Treatment 
Dose 
mg/kg 
SGOT 
(IU/L) 
Control Vehicle 45.46±0.24 
Toxic control 2 gm/kg 70.05±0.2 
Silymarine 100mg/kg 53.8±0.21 
Ethanol Extract  200mg/kg 56.21±0.2 
Ethanol Extract  400mg/kg 50.12±2.2 
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 7.4.3. Effect of ICLE on ALP concentration in paracetamol induced 
model 
ALP level in the control group increased from 55.02±0.59 IU/L to 
185.45±0.22 IU/L in paracetamol intoxicated rat as shown in Table 12. 
Administration of ICLE  200mg/kg and 400 mg/kg in paracetamol intoxicated 
rats lead to lowering of the ALP level  84.12±0.16 and 62.13± 1.27 
respectively (P<0.001). The extract in control animals showed no significant 
alteration in ALP level.  
 
Table.No:12:Effect of ICLE on ALP concentration in paracetamol 
induced     model 
 
 
Treatment 
Dose 
mg/kg 
ALP 
(IU/L) 
Control Vehicle 55.02±0.59 
Toxic control 2 gm/kg 185.45±0.22 
Silymarine 100mg/kg 75.7±0.21 
Ethanol Extract  200mg/kg 84.12±0.16 
Ethanol Extract  400mg/kg 62.13± 1.27 
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Figure .No:14:Effect of ICLE on ALP concentration in paracetamol 
induced model 
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7.4.4.Effect of ICLE on Total Proteins in paracetamol induced model 
 
           Total protein level in the control group reduced from 8.93±0.07g/dl to 
3.61±0.08 g/dl in paracetamol intoxicated rat as shown in Table 13. 
Administration of ICLE  200 mg/kg and 400 mg/kg in paracetamol intoxicated 
rats led to increasing the concentration  7.24±0.07 and 7.99±0.03 respectively 
(P<0.001). 
  
Table.No:13:Effect of ICLE on Total Proteins in paracetamol induced 
model 
 
 
 
 
 
 
 
        
 
Treatment 
Dose 
mg/kg 
Total  Protein 
(g/dl) 
Control Vehicle 8.93±0.07 
Toxic control 2 gm/kg 3.61±0.08# 
Silymarine 100mg/kg 8.40±0.06 
Ethanol Extract  200mg/kg 7.24±0.07 
Ethanol Extract  400mg/kg 7.99±0.03 
                                                                                       
 
 Page 66 
 
Figure .No:15: Effect of ICLE on Total Protein in paracetamol induced 
model 
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  7.4.5. Effect of ICLE on Total Bilurubin in paracetamol induced model 
 
Destruction of hemoglobin yields bilirubin which is conjugated in the 
liver to diglucoroxide and excreted in the bile. Bilirubin accumulates in plasma 
when liver insufficiency exists or biliary obstruction is present or rate of 
hemolysis increases. The total bilirubin level increased from 3.12±0.02 mg/dL 
in the control group to 12.21±0.04mg/dL after paracetamol intoxication as 
shown in Table 14 Administration of ICLE 200 mg/kg and 400 mg/kg in 
paracetamol  intoxicated rats reduced the total bilirubin to 7.60±0.09mg/dL 
and 5.13±0.56mg/dL (P<0.001). However, the extracts in control rats showed 
no such significant alteration in the serum bilirubin level. 
 
Table.No:14:Effect of ICLE on Total Bilurubin in paracetamol induced 
model 
 
 
 
 
 
Treatment 
Dose 
mg/kg 
Total  
bilirubin (mg/dl) Control Vehicle 3.12±0.02 
Toxic control 2 gm/kg 12.21±0.04# 
Standard  100mg/kg  4.86±0.21 
Ethanol Extract  200mg/kg   7.60±0.09 
Ethanol Extract  400mg/kg  5.13±0.56 
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Figure .No:16: Effect of ICLE on Total Bilurubin in paracetamol 
induced model 
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7.4.6. Effect of ICLE on Body Weight for paracetamol induced 
model 
                          Table 15represents the body weight ofdifferent groups of rat   
treatment. The body weight of Paracetamol induced group II rats has been re
duced comparing with group I.  The body weight of Paracetamol induced grou
p II rats has been reduced comparing with group I.After 28days administration
 of silymarin and ixora coccinea on group III and  group  VI  rats  has  gained  
the body weight almost to near normal level.  The gain in body weight of grou
p IV is compared with group II and it may be due to the regeneration of liver c
ells activity to near normal after the herbal treatment. 
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Table.No:15:Effect of ICLE on Body weight for paracetamol induced 
model 
 
Values expressed as Mean ±SEM; Number of animals in each group =6 
*P˂0.0001 
 
 
 
 
 
 
 
 
TREATMENT 
DAY % 
Change 
In Body 
Weight 
 
0 
 
7 
 
14 
 
 
21 
 
28 
 
Normal 
control 
144.13±6.3
4 
152.21±3.7 
165.21±3.8
5 
 
181.11±5.
35 
204.23±3.
8 
27.52% 
Toxic control 
142.19±6.8
5 
164.39±5.2
0 
174.25±4.2
1 
197.3±2.3
3 
224.13±6.
2 
35.87% 
Silymarine 
(100mg/kg) 
 
141.54±7.3
5 
151.20±3.8 
162.50±6.3
3 
177.5±3.9
5 
201.22±4.
5 
42.36% 
Ethanol 
extract 
(200mg/kg) 
142.32±4.5
5 
153.20±3.3
3 
163.22±2.4
4 
175.21±3.
75 
203.44±1.
37 
44.37 
Ethanol 
extract 
(400mg/kg) 
141.55±6.0
3 
151.11±1.4 
161.33±2.9
1 
179.14±2.
2 
209.14±2.
5 
47.78% 
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Figure .No:17: - Body weight change for Paracetamol induced model 
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7.5.HISTOPATHOLOGY 
Histology is the study of the microscopic anatomy of cells and tissues 
of plants and animals. Histology is an essential tool of biology and medicine. 
Histopathology, the microscopic study of diseased tissue, is an important tool 
in anatomical pathology, since accurate diagnosis of liver diseases usually 
requires histopathological examination of samples. 
The hepatoprotective effect of ICLE was confirmed by histological 
examination. The liver sections of normal control animals showed hepatic 
cells with well-preserved cytoplasm, prominent nucleus and central vein (Fig. 
9 Group 1). The normal architecture of liver was completely lost in rats treated 
with Paracetamol (Fig. 9 – Group 2) with the appearance of vacuolated 
hepatocytes and degenerated nuclei. Vacuolization, fatty metamorphosis in 
the adjacent hepatocytes, cell infiltration of lymphocytes and Kupffer cells and 
necrosis of hepatocytes were severe in the centrilobular region and these 
changes were also observed in areas other than the centrilobular regions. The 
livers of rats treated with ICLE 100mg/kg,200 mg/kg,400mg/kg (Fig. 9 group 
IV-VI), and  silymarin 100 mg/kg (Fig. 9 group III) showed a significant 
attenuation from paracetamol induced liver damage as evident from normal 
hepatocytes with well-defined nuclei.  
Histological features 
 Normal control shows normal cellular architecture with distinct hepatic 
cells, sinusoidal space and a central vein. 
 Toxic control exhibited severe hepatocyte degeneration, fatty changes 
and necrosis. 
 Silymarine shoes shows mild hepatocyte degeneration. 
 b ethanol extract shows normal architecture with mild hepatocyte 
degeneration through dose dependent  
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Figure .No:18: Histopathology study of ICLE 
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          CHAPTER VIII 
8.DISSCSSION 
The plant ixora coccinea is widely distributed in suth asia . The s flower 
part of  plant have been studied its antibacterial activity but the 
hepatoprotective effect have been never studied. Hence the objective of the 
study is determining this effect from the dried leaf extract of ixora coccinea 
The preliminary phytochemical screening  of whole plant extracts  
indicate in presence of flavanoid, terpenoids , protien and amino acid .  may 
accounts antioxidant and hepatoprotective activity.  
The antioxidant screening shows that that it showed reducing power to 
DPPH radicals. But the efficiency showed that far below from Vitamin C. The 
concentration of the ICLE needed to scavenge 50% superoxide anion (IC50) 
equal to that of standard hence the leaf juice have the significant antioxidant 
activity  
Liver is one of the important organs of body hence damage to liver 
leads to severe pathological problems or death. Liver diseases are mainly 
caused by toxic chemicals, excessive intake of alcohol, infections and 
autoimmune disorders. Liver injury caused by hepatotoxins such as carbon 
tetrachloride, ethanol and acetaminophen is characterized by varying degrees 
of hepatocyte degeneration and cell death by either apoptosis or by necrosis. 
SGOT, SGPT, ALP, Total Protein and Total Bilirubin levels are largely used 
as most common biochemical markers to evaluate liver injury. 
Paracetamol (Acetaminophen), a widely used analgesic and antipyretic 
drug that produces acute liver damage in high doses. Paracetamol induced 
hepatotoxicity is thought to be caused by N-acetyl-p-benzoquinoneimine 
(NAPQI), a cytochrome P-450 mediated intermediate metabolite. NAPQI can 
react with sulphydryl groups such as glutathione and protein thiols. The 
covalent binding of NAPQI to cell proteins is considered the initial step in a 
chain eventually leading to cell necrosis. In paracetamol (PCM) treated acute 
hepatic injury a significant difference in biochemical markers was observed 
between normal and PCM control groups. Results of present study shows that 
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the levels of SGOT, SGPT, ALP and Total Bilirubin were significantly 
increased in paracetamol treated groups when compared with normal control 
group.  
While total protein is decreased in paracetamol treated groups due to 
damage produced in endoplasmic reticulum. Comparative analysis on the 
effect of SGOT, SGPT, ALP and Total Bilirubin revealed that extracts shows 
marked decrease in these enzymes when compared with toxic control group.  
While silymarine, and extract  of ixora coccinea.  Significantly restored 
total protein activities to normal level. Moreover, histopathological analysis 
showed that normal liver architecture was disturbed by paracetamol treated 
rats oral feeding with extracts shows normal architecture with mild hepatocyte 
degeneration compared with normal control group.  
         The preliminary phytochemical screening of whole plant extracts 
indicate in presence of flavanoid, terpenoids , protien and amino acid .  
The antioxidant studies particularly showed that ICLE have slight antioxidant 
potential but that not inferior than standard vitamin C . 
Hepatoprotective study results shows that the levels of SGOT, SGPT, ALP 
and Total Bilirubin were significantly improvement may accounts 
hepatoprotective activity  
All these observation imply that the ICLE could be regarded as a favorable 
antioxidant and hepatoprotective agents. 
As the results indicated that the extract possess significant hepatoprotective 
activity, after carrying out a thorough study of clinical trials, the plant can be 
considered as a low cost, potent, herbal medicine for liver disorders. 
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